Feb 26, 2026 04:00PM
Feb 23, 2026 07:00AM
Jan 5, 2026 07:00AM
Nov 25, 2025 07:00AM
Nov 6, 2025 04:00PM
Oct 14, 2025 07:00AM
Oct 14, 2025 07:00AM Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)
Oct 10, 2025 04:00PM
Aug 28, 2025 07:00AM
Aug 20, 2025 07:00AM
Aug 20, 2025 07:00AM
Aug 7, 2025 04:00PM
Jul 24, 2025 07:00AM
Jul 24, 2025 07:00AM Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs
Jul 17, 2025 07:00AM
Jul 17, 2025 07:00AM
Jun 30, 2025 07:00AM
Jun 30, 2025 07:00AM
May 27, 2025 07:01AM
May 27, 2025 07:00AM
May 15, 2025 03:15PM Rocket Pharmaceuticals (RCKT) Presents Preliminary Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy
May 15, 2025 03:15PM
May 9, 2025 04:30PM
May 8, 2025 04:01PM
Apr 3, 2025 07:00AM
Feb 27, 2025 04:01PM
Jan 2, 2025 04:00PM
Nov 26, 2024 07:00AM Rocket Pharmaceuticals to Participate in the 7th Annual Evercore HealthCONx Conference
Nov 18, 2024 11:00AM
Nov 18, 2024 11:00AM
Nov 12, 2024 04:01PM
Nov 8, 2024 07:00AM
Nov 7, 2024 04:01PM
Sep 17, 2024 07:03AM
Sep 17, 2024 07:00AM Rocket Pharmaceuticals Announces Completion of Enrollment in Phase 2 Pivotal Trial of RP-A501 for the Treatment of Danon Disease
Sep 10, 2024 07:03AM
Sep 10, 2024 07:00AM
Aug 27, 2024 07:00AM
Aug 5, 2024 04:01PM
Jun 28, 2024 07:28AM
Jun 28, 2024 07:27AM
May 29, 2024 07:04AM Rocket Pharmaceuticals (RCKT) Receives Orphan Medicinal Product Designation from the European Commission for RP-A601
May 29, 2024 07:00AM
May 10, 2024 06:00AM
May 10, 2024 06:00AM
May 6, 2024 04:01PM
Apr 2, 2024 06:01AM
Apr 2, 2024 06:00AM
Mar 26, 2024 04:01PM Rocket Pharmaceuticals (RCKT) Appoints Aaron Ondrey as CFO
Mar 26, 2024 04:01PM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All